Cargando…
Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia – a case report
BACKGROUND: Premature preterm rupture of membranes (PPROM) is reported to be associated with high rates of neonatal mortality and morbidity. Sildenafil has been used in infants with persistent pulmonary hypertension of newborn (PPHN) due to congenital diaphragmatic hernia (CDH) and bronchopulmonary...
Autores principales: | Lavie-Nevo, Karen, Harris, Kevin C., Ting, Joseph Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833248/ https://www.ncbi.nlm.nih.gov/pubmed/31690278 http://dx.doi.org/10.1186/s12887-019-1801-3 |
Ejemplares similares
-
Is Sildenafil an Effective Therapy in the Management of Persistent Pulmonary Hypertension?
por: Yaseen, Hakam, et al.
Publicado: (2012) -
Black lung persistent pulmonary hypertension of the newborn: Saudi experience with sildenafil and nitric oxide
por: Alnemri, AbdulRahman M.
Publicado: (2017) -
Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021) -
Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants
por: Schroeder, Lukas, et al.
Publicado: (2023) -
Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)